Location History:
- Shanghai, CN (2018)
- Collegeville, PA (US) (2019)
Company Filing History:
Years Active: 2018-2019
Title: Ebere F Igboko: Innovator in CXCR2 Inhibitors
Introduction
Ebere F Igboko is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of CXCR2 inhibitors. With a total of 2 patents, his work focuses on innovative solutions for treating diseases mediated by the CXCR2 receptor.
Latest Patents
Ebere's latest patents include two related inventions:
1. **1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors** - This invention pertains to the use of 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives in treating or preventing diseases mediated by the CXCR2 receptor. It also covers compositions containing these derivatives and the processes for their preparation.
2. **1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors** - Similar to the first, this patent also focuses on the application of 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives for therapeutic purposes related to the CXCR2 receptor.
Career Highlights
Ebere F Igboko is currently associated with GlaxoSmithKline Intellectual Property Development Limited. His work at this prominent company has allowed him to explore and develop innovative pharmaceutical solutions.
Collaborations
Ebere has collaborated with notable coworkers, including Weichun Chen and Xichen Lin, who contribute to his research and development efforts.
Conclusion
Ebere F Igboko's contributions to the field of medicinal chemistry, particularly through his patents on CXCR2 inhibitors, highlight his innovative spirit and dedication to advancing healthcare solutions. His work continues to pave the way for new treatments and therapies.